Department of Infectious Diseases, State Key Laboratory of Antiviral Drugs, Pingyuan Laboratory, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Disease, National Medical Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
PLoS Pathog. 2024 Apr 3;20(4):e1012075. doi: 10.1371/journal.ppat.1012075. eCollection 2024 Apr.
Oropharyngeal microbiomes play a significant role in the susceptibility and severity of COVID-19, yet the role of these microbiomes play for the development of COVID-19 Omicron variant have not been reported. A total of 791 pharyngeal swab samples were prospectively included in this study, including 297 confirmed cases of Omicron variant (CCO), 222 confirmed case of Omicron who recovered (CCOR), 73 confirmed cases of original strain (CCOS) and 199 healthy controls (HC). All samples completed MiSeq sequencing. The results showed that compared with HC, conditional pathogens increased in CCO, while acid-producing bacteria decreased. Based on six optimal oropharyngeal operational taxonomy units (OTUs), we constructed a marker microbial classifier to distinguish between patients with Omicron variant and healthy people, and achieved high diagnostic efficiency in both the discovery queue and the verification queue. At same time, we introduced a group of cross-age infection verification cohort and Omicron variant subtype XBB.1.5 branch, which can be accurately distinguished by this diagnostic model. We also analyzed the characteristics of oropharyngeal microbiomes in two subgroups of Omicron disease group-severity of infection and vaccination times, and found that the change of oropharyngeal microbiomes may affect the severity of the disease and the efficacy of the vaccine. In addition, we found that some genera with significant differences gradually increased or decreased with the recovery of Omicron variant infection. The results of Spearman analysis showed that 27 oropharyngeal OTUs were closely related to 6 clinical indexes in CCO and HC. Finally, we found that the Omicron variant had different characterization of oropharyngeal microbiomes from the original strain. Our research characterizes oropharyngeal microbiomes of Omicron variant cases and rehabilitation cases, successfully constructed and verified the non-invasive diagnostic model of Omicron variant, described the correlation between microbial OTUs and clinical indexes. It was found that the infection of Omicron variant and the infection of original strain have different characteristics of oropharyngeal microbiomes.
口咽微生物组在 COVID-19 的易感性和严重程度中发挥着重要作用,但这些微生物组在 COVID-19 奥密克戎变体发展中的作用尚未报道。本研究共前瞻性纳入 791 例咽拭子样本,包括 297 例奥密克戎变异株确诊病例(CCO)、222 例奥密克戎变异株康复确诊病例(CCOR)、73 例原始株确诊病例(CCOS)和 199 例健康对照(HC)。所有样本均完成 MiSeq 测序。结果表明,与 HC 相比,CCO 条件致病菌增加,产酸菌减少。基于 6 个最佳口咽操作分类单元(OTUs),我们构建了一个标记微生物分类器来区分奥密克戎变异株患者和健康人,在发现队列和验证队列中均实现了较高的诊断效率。同时,我们引入了一组跨年龄感染验证队列和奥密克戎变异株亚型 XBB.1.5 分支,该诊断模型可准确区分。我们还分析了两组奥密克戎疾病组——感染严重程度和接种次数的口咽微生物组特征,发现口咽微生物组的变化可能影响疾病的严重程度和疫苗的效果。此外,我们发现一些具有显著差异的属随着奥密克戎变异株感染的恢复逐渐增加或减少。Spearman 分析结果表明,27 个口咽 OTUs 与 CCO 和 HC 中的 6 个临床指标密切相关。最后,我们发现奥密克戎变异株与原始株对口咽微生物组的特征不同。我们的研究对奥密克戎变异株病例和康复病例的口咽微生物组进行了特征描述,成功构建和验证了奥密克戎变异株的非侵入性诊断模型,描述了微生物 OTUs 与临床指标的相关性。研究发现奥密克戎变异株感染和原始株感染对口咽微生物组的特征不同。